154 related articles for article (PubMed ID: 15651602)
1. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism.
Matheoud R; Reschini E; Canzi C; Voltini F; Gerundini P
Med Phys; 2004 Dec; 31(12):3194-200. PubMed ID: 15651602
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
[TBL] [Abstract][Full Text] [Related]
3. Radiation exposure rate from 131I-treated hyperthyroid patients--a dynamic study, with data for up to 42 d post therapy.
Mohammadi H
Health Phys; 2005 May; 88(5):486-90. PubMed ID: 15824597
[TBL] [Abstract][Full Text] [Related]
4. Recommended restrictions after 131I therapy: measured doses in family members.
Mathieu I; Caussin J; Smeesters P; Wambersie A; Beckers C
Health Phys; 1999 Feb; 76(2):129-36. PubMed ID: 9929123
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
[TBL] [Abstract][Full Text] [Related]
6. Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131.
Cappelen T; Unhjem JF; Amundsen AL; Kravdal G; Følling I
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):81-6. PubMed ID: 16151768
[TBL] [Abstract][Full Text] [Related]
7. Restriction periods for carers, comforters and members of the public in the treatment of hyperthyroidism.
Mínguez P; Genolla J; Celeiro J; Fombellida JC
Radiat Prot Dosimetry; 2013; 154(3):285-92. PubMed ID: 22929557
[TBL] [Abstract][Full Text] [Related]
8. Potential third-party radiation exposure from patients undergoing therapy with 131I for thyroid cancer or metastases.
D'Alessio D; Giliberti C; Benassi M; Strigari L
Health Phys; 2015 Mar; 108(3):319-25. PubMed ID: 25627943
[TBL] [Abstract][Full Text] [Related]
9. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism.
Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A
Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of ocular lens ionizing radiation exposure after radioiodine therapy].
Andreeff M; Claussnitzer J; Oehme L; Freudenberg R; Kotzerke J
Nuklearmedizin; 2012; 51(3):79-83. PubMed ID: 22395665
[TBL] [Abstract][Full Text] [Related]
11. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
12. Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism.
Barrington SF; Anderson P; Kettle AG; Gadd R; Thomson WH; Batchelor S; Mountford PJ; Harding LK; O'Doherty MJ
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2097-104. PubMed ID: 18682934
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
14. Release of patients after therapy with unsealed radionuclides.
International Commission on Radiological Protection
Ann ICRP; 2004; 34(2):v-vi, 1-79. PubMed ID: 15571759
[TBL] [Abstract][Full Text] [Related]
15. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients.
Canzi C; Zito F; Voltini F; Reschini E; Gerundini P
Med Phys; 2006 Aug; 33(8):2860-7. PubMed ID: 16964862
[TBL] [Abstract][Full Text] [Related]
16. An engagement factor for caregiver radiation dose assessment with radioiodine treatment.
Lee HK; Hong SJ; Jeong KH; Jung JW; Kim SM; Kang YH; Han MS
Radiat Prot Dosimetry; 2015 Mar; 163(4):499-508. PubMed ID: 25028695
[TBL] [Abstract][Full Text] [Related]
17. Estimating radiation absorbed dose of individuals nearby 131I-treated hyperthyroid patients.
Cui S; Jiao L; Tan J; Zhang G; Zhang H; Long W; Fan S; Zhang W
Health Phys; 2014 Mar; 106(3):365-9. PubMed ID: 25208013
[TBL] [Abstract][Full Text] [Related]
18. RADIATION PROTECTION IN THE RELEASE OF PATIENTS RECEIVING 131I TREATMENT.
Mattar E; Salih MA; Alsafi K; Suliman II
Radiat Prot Dosimetry; 2019 Dec; 187(4):499-508. PubMed ID: 31605121
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
[TBL] [Abstract][Full Text] [Related]
20. Is it safe to work with iodine-131 if you are pregnant? A risk assessment for nuclear medicine staff involved with cleaning and decontamination.
Barber RW; Parkin A; Goldstone KE
Nucl Med Commun; 2003 May; 24(5):571-4. PubMed ID: 12717076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
